From: Low Percentage of KRAS Mutations Revealed by Locked Nucleic Acid Polymerase Chain Reaction: Implications for Treatment of Metastatic Colorectal Cancer
RP/RC
SD
PD
Total
All
29 (30.5%)
37 (38.9%)
95
WT/WT
23 (36.5%)
22 (34.9%)
18 (28.6%)
63
WT/mutated
6 (18.75%)
15 (46.85%)
11 (34.4%)
32